Schedule a COVID vaccine or booster appointment:
Log in to myPennMedicine or call us 8am to 5pm, Monday through Friday, at 267-758-4902.
Sees patients age 18 and up
Sees patients age 18 and up
Perelman Center for Advanced Medicine
South Pavilion, 2nd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
330 South 9th Street
Philadelphia, PA 19107
A facility of Pennsylvania Hospital
The Patient Satisfaction Rating is an average of all responses to the care provider related question shown above from our internal platform, PMX Feedback. Responses are measured on a scale of 1 to 5 with 5 being the best score. Scores reflect either the most recent 12 months of surveys or the most recent 30 surveys overall. Data is updated monthly and comments remain on the profile for 12 months.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Patients that are treated in outpatient or hospital environments may receive different surveys.
Hina Dave, MD - UT Southwestern Medical Center; Jacqueline French, MD - NYU Comprehensive Epilepsy Center; Hamada Hamid Altalib, DO, MPH, FAES - Yale University; Heidi Henninger, MD - Maine Medical Center; Roger Porter, MD, ScD - Perelman School of Medicine, University of Pennsylvania; Michael Gelfand, MD, PhD - University of Pennsylvania; Melinda Martin, PhD - UCB Pharma, Smyrna; Prashant Dongre, MD - UCB Pharma, Smyrna; Sami Elmoufti, MS - UCB Pharma, Raleigh; Anne-Liv Schulz, MD - UCB Pharma, Monheim am Rhein; Michael Sperling, MD - Thomas Jefferson University: Real-World Study of Brivaracetam in the United States American Epilepsy Society : 2021.
Sen A, Verner R, Valeriano JP, Lee R, Zafar M, Thomas R, Kotulska K, Jespers E, Dibué M, Kwan P; CORE-VNS Registry Group.: Vagus nerve stimulation therapy in people with drug-resistant epilepsy (CORE-VNS): rationale and design of a real-world post-market comprehensive outcomes registry BMJ Neurol Open 3 : e000218,2021.
Syndi Seinfeld, DO - Joe DiMaggio Children’s Hospital; Carla Buan - Aquestive Therapeutics; Michael Gelfand - University of Pennsylvania; Allen Heller - Pharma Study Design, LLC; Ayman Kafal - Aquestive Therapeutics; gary Slatko - Aquestive Therapeutics: Diazepam Buccal Film (DBF): Final Results from a Phase 3, Open-Label, Safety and Tolerability Study of Chronic Intermittent Use in Pediatric, Adolescent and Adult Subjects with Epilepsy American Epilepsy Society : 2021.
Manisha Holmes; aaron smith; Dennis Dlugos; Michael Gelfand; tricia Ting; Orrin Devinsky; Jacqueline French: Differentiating Generalized Epilepsy vs Focal Epilepsy with Secondary Bilateral Synchrony in Newly Diagnosed Patients American Epilepsy Society : 2021.
Heidi Henninger, MD - Maine Medical Center; Michael Sperling, MD – Thomas Jefferson University; Hamada Hamid Altalib, DO, MPH – Yale University; Hina Dave, MD – University of Texas Southwestern Medical Center; Michael Gelfand, MD, PhD – University of Pennsylvania; Roger Porter, MD - University of Pennsylvania; Melinda Martin, PhD – UCB Pharma, Smyrna; Sami Elmoufti, MS – UCB Pharma, Raleigh; Anne-Liv Schulz, MD – UCB Pharma, Monheim am Rhein; Prashant Dongre, MD – UCB Pharma, Smyrna; Jacqueline French, MD – NYU Comprehensive Epilepsy Center: Effectiveness and Tolerability of Brivaracetam by Reason for Initiation in Adults with Focal Seizures: Post-hoc Analysis of a Real-world, US Study American Epilepsy Society : 2021.
Hamada Hamid Altalib, DO, MPH - Yale University; Jacqueline French, MD – New York University Comprehensive Epilepsy Center; Michael Sperling, MD – Thomas Jefferson University; Heidi Henninger, MD – Maine Medical Partners Neurology; Hina Dave, MD – University of Texas Southwestern Medical Center; Michael Gelfand, MD, PhD – University of Pennsylvania; Anne-Liv Schulz, MD – UCB Pharma, Monheim am Rhein; Sami Elmoufti, MS – UCB Pharma, Raleigh; Prashant Dongre, MD – UCB Pharma, Smyrna; Melinda Martin, PhD – UCB Pharma, Smyrna: Patient-reported Outcomes in Mood, Fatigue, Sleep Disturbance, and Disability While on Brivaracetam Treatment: A Prospective Observational Study American Epilepsy Society : 2021.
Jacqueline A French 1, Andrew J Cole 1, Edward Faught 1, William H Theodore 1, Annamaria Vezzani 1, Kore Liow 1, Jonathan J Halford 1, Robert Armstrong 1, Jerzy P Szaflarski 1, Sarah Hubbard 1, Jagdish Patel 1, Kun Chen 1, Wei Feng 1, Marco Rizzo 2, Jacob Elkins 1, Gabrielle Knafler 1, Kimberly A Parkerson 1, OPUS Study Group [As member of OPUS Study Group]: Safety and Efficacy of Natalizumab as Adjunctive Therapy for People With Drug-Resistant Epilepsy: A Phase 2 Study Neurology 97 (18): e1757-1767,2021.
Alisha Jamil, Noah Levinson, Michael Gelfand, Chloe E Hill, Pouya Khankhanian, Kathryn A Davis: Efficacy and Tolerability of Clobazam in Adults With Drug-Refractory Epilepsy Neurol Clin Pract 11 (5): e669-676,2021.
Acton EK, Khazaal O, Willis AW, Gelfand MA, Hennessy S, Selim MH, Kasner SE.: Statins for the Prevention of Post-Stroke Seizure and Epilepsy Development: A Systematic Review and Meta-Analysis J Stroke Cerebrovasc Dis 30 : 106024,2021.
Tatum WO, Hirsch LJ, Gelfand MA, Acton EK, LaFrance WC, Duckrow RB, Chen D, Blum AS, Hixson J, Drazkowski J, Benbadis S, Cascino GD; OSmartViE Collaborators.: Video quality using outpatient smartphone videos in epilepsy: Results from the OSmartViE study. Eur J Neurol. 28 (5): 1453-1462,2021.
Department of NeurologyHospital of the University of Pennsylvania3400 Spruce Street
Patient appointments: 800-789-7366